Last edition
News about "Celiac Disease"
argenx to Acquire Forte Biosciences
argenx will acquire Forte Biosciences to add the first-in-class anti-CD122 antibody FB102, expanding its immunology pipeline.
Celiac Disease | 27/07/2026 | By News Bureau
EVOQ Therapeutics Receives USD 2 Million NIH Grant to Develop Therapies for Celiac Disease
The NIH award represents a significant endorsement of EVOQ's ground-breaking approach to harnessing the power of the immune system to treat and prevent autoimmune diseases.
Celiac Disease | 14/10/2025 | By Dineshwori | 296
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy